Table 2 Prevalence of Individual FCI Comorbidities by Data Collection Method (n = 59)
From: The functional comorbidity index had high inter-rater reliability in patients with acute lung injury
FCI Comorbidity, n (%) | Gold Standard Chart Abstraction | Prospective: Admission Records | p-value* | Retrospective: Discharge Summaries | p-value** |
|---|---|---|---|---|---|
Arthritis (rheumatoid and osteoarthritis) | 5 (8) | 1 (3) | 0.05 | 3 (5) | 0.41 |
Osteoporosis | 0 (0) | 0 (0) | n/a | 1 (2) | 0.32 |
Asthma | 7 (12) | 2 (3) | 0.03 | 6 (10) | 0.32 |
COPD, emphysema, or ARDS | 7 (12) | 0 (0) | <0.01 | 5 (8) | 0.32 |
Angina | 1 (2) | 0 (0) | 0.32 | 0 (0) | 0.32 |
Congestive heart failure (or heart disease) | 10 (17) | 5 (8) | 0.05 | 8 (14) | 0.16 |
Myocardial infarction | 2 (3) | 2 (3) | 1.00 | 1 (2) | 0.32 |
Neurological disease (e.g., MS or Parkinson’s) | 6 (10) | 0 (0) | 0.01 | 8 (14) | 0.16 |
Stroke or TIA | 4 (7) | 5 (8) | 0.32 | 4 (7) | 1.00 |
Peripheral vascular disease | 4 (7) | 1 (3) | 0.08 | 3 (5) | 0.32 |
Diabetes type I or II | 10 (17) | 9 (15) | 0.56 | 10 (17) | 1.00 |
Upper GI disease (e.g., ulcer, hernia, reflux) | 23 (39) | 4 (7) | <0.01 | 24 (41) | 0.71 |
Depression | 15 (25) | 3 (5) | <0.01 | 11 (19) | 0.16 |
Anxiety or panic disorders | 6 (10) | 0 (0) | 0.01 | 6 (10) | 1.00 |
Visual impairment (e.g., cataracts, glaucoma) | 0 (0) | 0 (0) | 1.00 | 1 (2) | 0.32 |
Hearing impairment (e.g., hard of hearing with aids) | 0 (0) | 0 (0) | n/a | 0 (0) | n/a |
Degenerative disc disease (e.g., spinal stenosis) | 3 (5) | 0 (0) | 0.08 | 2 (3) | 0.32 |
FCI Score, median (IQR)*** | 2 (1–3) | 1 (0–1) | <0.01 | 1 (1–2) | <0.01 |